Kaposi's sarcoma-associated herpesvirus infection in chronic hepatitis B patients
10.3760/cma.j.issn.1000-6680.2010.02.005
- VernacularTitle:慢性乙型肝炎患者卡波西肉瘤相关疱疹病毒感染状态及特点分析
- Author:
Biao ZHU
;
Yirui XIE
;
Nanping WU
;
Yagang CHEN
;
Minjun HU
;
Liwei CHEN
- Publication Type:Journal Article
- Keywords:
Sarcoma;
Herpesvirus infections;
Hepatitis B;
chronic;
Virus replication;
Polymerase chain reaction;
Glycyrrhizic acid
- From:Chinese Journal of Infectious Diseases
2010;28(2):86-88
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study Kaposi's sarcoma-associated herpesvirus(KSHV)infection in chronic hepatitis B(CHB)patients and its correlation with hepatitis B virus(HBV)replication and treatment-related factors.MethodsEnzyme-linked immunosorbent assay(ELISA)with recombination protein KSHV ORF65 was employed to detect the KSHV antibody and real-time polymerase chain reaction(PCR)was performed to detect KSHV DNA and HBV DNA in CHB patients.Age,HBV replication and licorice preparation treatment of patients were further analyzed.Comparison of rates was done using X~2 test.Results KSHV ORF65 antibody positive rates were 27.3% in 161 male CHB patients and 30.0% in 50 female patients(X~2=0.135,P＞0.05).The KSHV infection rates were increased with age,but this tendency was not obvious in patients older than 40 years old.The highest infection rate was in age group of 31-40 years old which was 37.1%.The positive rate of HBV DNA in CHB patients with KSHV infection was 73.5%,which was 56.3% in uninfected patients(X~2=3.969,P＜0.05).The average plasma level of KSHV DNA in patients treated with licorice preparations was 204.7 copy/mL and that in patients without licorice preparation treatment was 533.9 copy/mL.Eight patients were KSHV DNA positive(KSHV DNA＞ 100 copy/mL)in 16 patients treated with licorice preparations and 23 were positive in 33 patients without licorice preparation treatment.Conclusions The KSHV infection rates are increased with age of CHB patients.KSHV infection may interfere with HBV replication and licorice preparations may suppresss KSHV replication in vivo.
